You searched for "Ophthalmoscopy"
Surgitrac confirms 2026 events so far
Surgitrac Instruments is delighted to announce the first confirmed meetings for our 2026 events calendar, where our team will once again be out on the road meeting ophthalmic professionals across the UK. Our Clinical Specialists will be representing Surgitrac at...Raphaél Ervinckx joins Glaukos
Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...
Outline of clinical care for healthy newborns with uncomplicated conjunctivitis in the US
The purpose of this study was to explore the current state of clinical care for healthy newborns with uncomplicated ophthalmia neonatorum (ON) using a large electronic health record dataset. Despite the existence of national guidelines for antepartum screening for N....Mainline Instruments at 100%
Visit Mainline Instruments at STAND J20 during 100% Optical 2026 for an exciting programme of interactive workshops and expert-led lectures on the latest eye care innovations. Highlights include Ultra-Widefield Confocal Imaging, Dry Eye assessment, Tomography, and more. Don’t miss our...
How does presentation, progression and outcome of new onset diplopia vary between older and younger adults?
The authors present a retrospective case review with the aim of comparing the frequency of different causes for new onset binocular diplopia in 2 age groups, above and below 65 years old. Adult patients with new onset diplopia within a...
Selective laser trabeculoplasty after medical treatment
Selective laser trabeculoplasty (SLT) is a well-established treatment for open-angle glaucoma (OAG) and ocular hypertension (OHT). This post-hoc secondary analysis of the LiGHT trial extension examined SLT as a secondary intervention after 3 years of protocolised medical therapy in patients...
Low-dose bimatoprost/timolol gel: a new fixed-combination option
This phase III international randomised trial evaluated the efficacy and safety of a new low concentration bimatoprost/timolol eye gel (bimatoprost 0.01%/timolol 0.1%). It was compared with the conventional higher-strength fixed combination eye drops (bimatoprost 0.03%/timolol 0.5%) in patients with open-angle...
